Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Psychosis”

185 trials

Showing 20 of 185 results

Post-approval studies (Phase 4)Study completedNCT00436371
What this trial is testing

Amisulpride in Schizophrenic Acute Phase Patients

Who this might be right for
Schizophrenia
Sanofi 50
Large-scale testing (Phase 3)Ended earlyNCT00486798
What this trial is testing

FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder
AstraZeneca
Post-approval studies (Phase 4)Study completedNCT00954122
What this trial is testing

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 35
Large-scale testing (Phase 3)Study completedNCT02109562
What this trial is testing

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Who this might be right for
Schizophrenia
Indivior Inc. 354
Early research (Phase 1)Study completedNCT00102479
What this trial is testing

Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents

Who this might be right for
SchizophreniaMania
Otsuka Pharmaceutical Development & Commercialization, Inc. 21
Large-scale testing (Phase 3)Study completedNCT00136994
What this trial is testing

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160
Testing effectiveness (Phase 2)Ended earlyNCT02088060
What this trial is testing

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 150
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Not applicableStudy completedNCT02095496
What this trial is testing

Efficacy of Closed-loop Ventilation to Reduced Sleep Disorders

Who this might be right for
Acute Mechanical Ventilatory FailurePsychosis Associated With Intensive Care
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 16
Testing effectiveness (Phase 2)Study completedNCT00628290
What this trial is testing

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

Who this might be right for
Schizophrenia
University of Cologne 42
Post-approval studies (Phase 4)Study completedNCT00080327
What this trial is testing

Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 370
Not applicableStudy completedNCT01544608
What this trial is testing

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 1,076
Not applicableStudy completedNCT03404882
What this trial is testing

Peer Support Experience for Patients Discharged From Acute Psychiatric Care

Who this might be right for
DepressionBipolar DisorderSchizophrenia
University of Alberta 182
Not applicableStudy completedNCT01232790
What this trial is testing

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia

Who this might be right for
Schizophrenia
Yale University 28
Not applicableStudy completedNCT01020409
What this trial is testing

INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery

Who this might be right for
Systemic Inflammatory Response Syndrome
Medical University of Gdansk 525
Not applicableUnknownNCT04161209
What this trial is testing

Citalopram and Stress Reactivity

Who this might be right for
DepressionDepressive DisorderMental Disorder+3 more
University of Oxford 40
Testing effectiveness (Phase 2)Study completedNCT00563706
What this trial is testing

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 199
Large-scale testing (Phase 3)Study completedNCT01617187
What this trial is testing

The Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

Who this might be right for
Schizophrenia
Organon and Co 360
Not applicableStudy completedNCT00399334
What this trial is testing

PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Janssen-Cilag, S.A. 1,607
Testing effectiveness (Phase 2)Study completedNCT04512066
What this trial is testing

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 287
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation